Results

Total Results: 756 records

Showing results for "recognized".

301. Disposition of Comments for Technical Brief 27 Patient Safety (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ambulatory-safety_disposition-comments.pdf
     October 19, 2016 - Ambulatory sensitive admissions are a longstanding, recognized adverse event that reflect breakdowns

302. Untitled (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/suicide-prevention_research-protocol.pdf
     December 23, 2015 - competent school community in which help seeking is encouraged and modeled and suicidal behavior is recognized

303. Disposition of Comments Report for Technical Brief 14 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-survivor-care-transition_disposition-comments.pdf
     March 18, 2014 - Disposition of Comments Report for Technical Brief 14 Technical Brief Disposition of Comments Report Research Review Title: Models of Cancer Survivorship Care Draft review available for public comment from August 9, 2013 to September 5, 2013. Research Review Citation: Viswanathan M, Halpern M, Sw…

304. AHRQ’s Evidence-based Practice Center Program Annual Report 2023 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-year-in-review-2023.pdf
     January 01, 2023 - This manuscript was recognized by the American College of Physicians Annals of Internal Medicine as

305. AHRQ's Evidence-based Practice Center Division Annual Report 2022: Solving the Puzzle for Evidence-Based Decision Making (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-year-in-review-2022.pdf
     January 01, 2022 - The Journal of Addiction Medicine recognized as its most downloaded article of 2021 an article based

306. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - Liraglutide might face fewer accessibility issues because it is a recognized T2DM treatment and because … (Saxenda) is a synthetic analog of the peptide hormone glucagon- like peptide-1 (GLP-1), which is recognized

307. Traumatic Brain Injury and Depression (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-brain-injury_executive.pdf
     April 01, 2011 - publications that provided a clear description of study participants and that used standardized tools and recognized

308. Procalcitonin Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/procalcitonin_executive.pdf
     October 01, 2012 - Although the importance of reducing antibiotic use is recognized, there was insufficient evidence from

309. Infantile-Hemangioma Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/infantile-hemangioma_executive.pdf
     January 01, 2016 - Some types of IH, specifically segmental hemangiomas, are recognized as high risk, but no consensus … While well-recognized clinical signs such as ulceration, airway obstruction, or vision-threatening

310. Disposition of Comments for CER 159 Insomnia (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/insomnia_disposition-comments.pdf
     December 30, 2015 - As the report recognized, study withdrawal may reflect aspects of motivation and a participant's external … published trials knowingly adopted the pro- manufacturer-bias of published work which it had partially recognized

311. Disposition of Comments Report for Comparative Effectiveness Review No. 131 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/crohns-disease_disposition-comments.pdf
     February 25, 2014 - Disposition of Comments Report for Comparative Effectiveness Review No. 131 Comparative Effectiveness Research Review Disposition of Comments Report Research Review Title: Pharmacologic Therapies for the Management of Crohn’s Disease: Comparative Effectiveness Draft review available for public commen…

312. Future Research Needs for Diagnosis of Obstructive Sleep Apnea (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/sleep-apnea-diagnosis-future_research.pdf
     February 01, 2012 - Future Research Needs for Diagnosis of Obstructive Sleep Apnea Future Research Needs Paper Number 11 Future Research Needs for Diagnosis of Obstructive Sleep Apnea Future Research Needs Paper Number 11 Future Research Needs for Diagnosis of Obstructive Sleep Apnea Identification of Future Research …

313. Disposition of comments_Comparative Effectiveness Review No. 244: Safety of Vaccines Used for Routine Immunization in the United States: An Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-244-safety-of-vaccines.pdf
     May 25, 2021 - presents an enormous amount of information and reflects considerable work by the authors who should be recognized

314. Disposition of Comments_Comparative Effectiveness Review No. 267: ADHD Diagnosis and Treatment in Children and Adolescents (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-267-adhd-disposition-comments.pdf
     March 25, 2024 - Disposition of Comments_Comparative Effectiveness Review No. 267: ADHD Diagnosis and Treatment in Children and Adolescents Comparative Effectiveness Review Disposition of Comments Report Ti…

315. Disposition of Comments for Comparative Effectiveness Review No. 240: Treatments for Acute Pain: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-240-acute-pain-revised-comments.pdf
     December 29, 2020 - Disposition of Comments for Comparative Effectiveness Review No. 240: Treatments for Acute Pain: A Systematic Review Comparative Effectiveness Review Disposition of Comments Report Research Review Title: Treatments for Acute Pain: A Systematic Review Draft report available for public comment from August 31, 2020,…

316. Disposition of Comments for Efficacy and Safety of Screening for Postpartum Depression (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-postpartum-screening_disposition-comments.pdf
     May 01, 2013 - If a greater continuity had been recognized, some flaws in the approach taken by these investigators … The work that underlies that recommendation and the larger societal context has to be recognized in … Section Comment Response Peer Reviewer 6 General The authors note that major US organizations have recognized

317. Disposition of Comments Report for Childhood Obesity Prevention Programs: A Comparative Effectiveness Review and Meta-Analysis (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/obesity-child_disposition-comments.pdf
     June 10, 2013 - However, we recognized that both types of interventions (individual verse group targeted ones) could

318. Methods Guide for Comparative Effectiveness Reviews - Avoiding Bias in Selecting Studies (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-bias_methods.pdf
     February 01, 2013 - Methods Guide for Comparative Effectiveness Reviews - Avoiding Bias in Selecting Studies Methods Guide for Comparative Effectiveness Reviews Avoiding Bias in Selecting Studies ii This report is based on research conducted by the Oregon Health & Science Uni…

319. antibiotics-respiratory-infection-protocol-140922 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/antibiotics-respiratory-infection_research-protocol.pdf
     September 22, 2014 - antibiotics-respiratory-infection-protocol-140922 Evidence-based Practice Center Systematic Review Protocol Project Title: Interventions to Improve Appropriate Antibiotic Use for Acut…

320. Plasma-Cell-Dyscrasias-Sflc-Assay Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/plasma-cell-dyscrasias-sflc-assay_executive.pdf
     August 01, 2012 - 1 Comparative Effectiveness Review Number 73 Serum Free Light Chain Analysis for the Diagnosis, Management, and Prognosis of Plasma Cell Dyscrasias Executive Summary Background Plasma cell dyscrasias (PCDs) are a group of neoplastic disorders characterized by the uninhibited expansion of a monoclonal popula…